Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Capellà, Dolors
and
Figueras, Albert
1992.
Vol. 16,
Issue. ,
p.
39.
Bruhwyler, J.
Chleide, E.
Houbeau, G.
Waegeneer, N.
and
Mercier, M.
1993.
Differentiation of haloperidol and clozapine using a complex operant schedule in the dog.
Pharmacology Biochemistry and Behavior,
Vol. 44,
Issue. 1,
p.
181.
Stevens, I.
and
Gaertner, H. J.
1994.
Clozapin Pharmakologie und Klinik eines atypischen Neuroleptikums.
p.
59.
Davé, Mahendra
1995.
Iatrogenic Salivary Gland Swelling.
Journal of Pharmacy Technology,
Vol. 11,
Issue. 1,
p.
18.
Liégeois, Jean‐Francois
Rogister, Francoise
Delarge, Jacques
and
Pincemail, Joël
1995.
Peroxidase‐catalysed oxidation of different dibenzazepine derivatives.
Archiv der Pharmazie,
Vol. 328,
Issue. 2,
p.
109.
Fritze, Jürgen
and
Elliger, Tilmann
1995.
Pirenzepine for clozapine-induced hypersalivation.
The Lancet,
Vol. 346,
Issue. 8981,
p.
1034.
Ben-Aryeh, H.
Jungerman, T.
Szargel, R.
Klein, E.
and
Laufer, D.
1996.
Salivary flow-rate and composition in schizophrenic patients on clozapine: Subjective reports and laboratory data.
Biological Psychiatry,
Vol. 39,
Issue. 11,
p.
946.
1996.
Improvement of clozapine-induced sialorrhea after septoplasty.
American Journal of Psychiatry,
Vol. 153,
Issue. 3,
p.
444.
Barnes, Thomas R. E.
McEvedy, Christopher J. B.
and
Nelson, Hazel E.
1996.
Management of Treatment Resistant Schizophrenia Unresponsive to Clozapine.
British Journal of Psychiatry,
Vol. 169,
Issue. S31,
p.
31.
Pantelis, Christos
and
Barnes, Thomas R.E.
1996.
Drug Strategies and Treatment-Resistant Schizophrenia.
Australian & New Zealand Journal of Psychiatry,
Vol. 30,
Issue. 1,
p.
20.
1996.
Porphyria cutanea tarda associated with carbamazepine treatment.
American Journal of Psychiatry,
Vol. 153,
Issue. 3,
p.
443b.
Auzou, P.
Özsancak, C.
Hannequin, D.
Moore, N.
and
Augustin, P.
1996.
Clozapine for the treatment of psychosis in Parkinson's disease: a review.
Acta Neurologica Scandinavica,
Vol. 94,
Issue. 5,
p.
329.
Davydov, Liya
and
Botts, Sheila R
2000.
Clozapine-Induced Hypersalivation.
Annals of Pharmacotherapy,
Vol. 34,
Issue. 5,
p.
662.
Rogers, Donald P.
and
Shramko, Jennifer K.
2000.
Therapeutic Options in the Treatment of Clozapine‐Induced Sialorrhea.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 20,
Issue. 9,
p.
1092.
Cree, Adrian
Mir, Shameem
and
Fahy, Thomas
2001.
A review of the treatment options for clozapine-induced hypersalivation.
Psychiatric Bulletin,
Vol. 25,
Issue. 3,
p.
114.
Liégeois, Jean-François
Eyrolles, Laurence
Ellenbroek, Bart A.
Lejeune, Christel
Carato, Pascal
Bruhwyler, Jacques
Géczy, Joseph
Damas, Jacques
and
Delarge, Jacques
2002.
New Pyridobenzodiazepine Derivatives: Modifications of the Basic Side Chain Differentially Modulate Binding to Dopamine (D4.2, D2L) and Serotonin (5-HT2A) Receptors.
Journal of Medicinal Chemistry,
Vol. 45,
Issue. 23,
p.
5136.
Iqbal, Mohammad Masud
Aneja, Alka
Rahman, Atiq
Megna, James L
Yasmin, Laila
Schwartz, Thomas L
Osmany, Saabry
and
Alam, Mohammed Adnan
2004.
Therapeutic Options in the Treatment of Clozapine-Induced Adverse Effects.
Journal of Pharmacy Technology,
Vol. 20,
Issue. 3,
p.
155.
Hagenah, J.
Kahl, K. G.
Steinlechner, S.
Lencer, R.
and
Klein, C.
2005.
Die Behandlung der Sialorrhö mit Botulinum-Toxin.
Der Nervenarzt,
Vol. 76,
Issue. 4,
p.
418.
Fitzsimons, Joanna
Berk, Michael
Lambert, Timothy
Bourin, Michel
and
Dodd, Seetal
2005.
A review of clozapine safety.
Expert Opinion on Drug Safety,
Vol. 4,
Issue. 4,
p.
731.
Kahl, K. G.
Trillenberg, P.
Kordon, A.
Lencer, R.
Klein, C.
and
Hagenah, J.
2005.
Therapie der Clozapin-induzierten Hypersalivation mit Botulinum-Toxin B.
Der Nervenarzt,
Vol. 76,
Issue. 2,
p.
205.
eLetters
No eLetters have been published for this article.